{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:33:00Z","timestamp":1757701980949},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s11906-006-0049-0","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T19:32:30Z","timestamp":1180035150000},"page":"185-190","source":"Crossref","is-referenced-by-count":3,"title":["Hypertension and heart failure: Diagnosis and management"],"prefix":"10.1007","volume":"8","author":[{"given":"Kevin A.","family":"Courville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector O.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"49_CR1","first-page":"2003","volume-title":"Heart Disease and Stroke Statistics Update","author":"American Heart Association","year":"2004","unstructured":"American Heart Association: Heart Disease and Stroke Statistics 2004 Update. Dallas, TX: American Heart Association; 2003."},{"key":"49_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11886-002-0049-x","volume":"4","author":"MR Mehra","year":"2002","unstructured":"Mehra MR, Uber PA, Potluri S, Ventura O: Is heart failure with preserved systolic function an overlooked enigma? Curr Cardiol Rep 2002, 4:187\u2013193.","journal-title":"Curr Cardiol Rep"},{"key":"49_CR3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0735-1097(01)01567-4","volume":"38","author":"M Senni","year":"2001","unstructured":"Senni M, Redfield MM: Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 2001, 38:1277\u20131282.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR4","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","volume":"33","author":"RS Vasan","year":"1999","unstructured":"Vasan RS, Larson MG, Benjamin EJ, et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33:1948\u20131955.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0735-1097(95)00381-9","volume":"26","author":"RS Vasan","year":"1995","unstructured":"Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565\u20131574.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"MN Redfield","year":"2003","unstructured":"Redfield MN, Jacobsen SJ, Burnett JC, et al.: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of heart failure epidemic. JAMA 2003, 289:194\u2013202. Excellent epidemiologic paper on the burden of heart failure on the community.","journal-title":"JAMA"},{"key":"49_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archinte.159.1.29","volume":"159","author":"M Senni","year":"1999","unstructured":"Senni M, Tribouilloy CM, Rodeheffer RJ, et al.: Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 1999, 159:29\u201334.","journal-title":"Arch Intern Med"},{"key":"49_CR8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archinte.1996.00440020046007","volume":"156","author":"RS Vasan","year":"1996","unstructured":"Vasan RS, Benjamin EJ, Levy D: Congestive heart failure with normal left ventricular systolic function: clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Inter Med 1996, 156:146\u2013157.","journal-title":"Arch Inter Med"},{"key":"49_CR9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00001573-200207000-00008","volume":"17","author":"M Slama","year":"2002","unstructured":"Slama M, Susic D, Varagic J, et al.: Diastolic dysfunction in hypertension. Curr Opin Cardiol 2002, 17:368\u2013373.","journal-title":"Curr Opin Cardiol"},{"key":"49_CR10","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP, et al.: Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106:3068\u20133072.","journal-title":"Circulation"},{"key":"49_CR11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","volume":"161","author":"J He","year":"2001","unstructured":"He J, Ogden LG, Bazzano LA, et al.: Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001, 161:996\u20131002.","journal-title":"Arch Intern Med"},{"key":"49_CR12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1136\/hrt.72.2_Suppl.S3","volume":"72","author":"WB Kannel","year":"1994","unstructured":"Kannel WB, Ho K, Thom T: Changing epidemiological features of cardiac failure. Br Heart J 1994; 72:S3-S9.","journal-title":"Br Heart J"},{"key":"49_CR13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0008-6363(99)00399-5","volume":"45","author":"L Mandinov","year":"2000","unstructured":"Mandinov L, Eberli FR, Seiler C, et al.: Diastolic heart failure. Cardiovasc Res 2000, 45:813\u2013825.","journal-title":"Cardiovasc Res"},{"key":"49_CR14","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.HYP.34.4.782","volume":"34","author":"ED Frohlich","year":"1999","unstructured":"Frohlich ED: Risk mechanisms in hypertensive heart disease. Hypertension 1999, 34:782\u2013789.","journal-title":"Hypertension"},{"key":"49_CR15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00001573-199409000-00008","volume":"9","author":"FM Fouad-Tarazi","year":"1994","unstructured":"Fouad-Tarazi FM: Left ventricular diastolic dysfunction in hypertension. Curr Opin Cardiol 1994, 9:551\u2013560.","journal-title":"Curr Opin Cardiol"},{"key":"49_CR16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00001573-199909000-00003","volume":"14","author":"HO Ventura","year":"1999","unstructured":"Ventura HO, Loyalka P, Smart FW: Treatment of the hypertensive patient with microvascular angina. Curr Opin Cardiol 1999, 14:370\u2013374.","journal-title":"Curr Opin Cardiol"},{"key":"49_CR17","first-page":"48","volume":"81","author":"JN Cohn","year":"1990","unstructured":"Cohn JN, Johnson G: Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation 1990, 81:48\u201353.","journal-title":"Circulation"},{"key":"49_CR18","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0735-1097(99)00374-5","volume":"34","author":"SH Dunlap","year":"1999","unstructured":"Dunlap SH, Sueta CA, Adams KF: Association of body mass, gender, race with heart failure primarily due to hypertension. J Am Coll Cardiol 1999, 34:1602\u20131608.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR19","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.1987.252.1.C1","volume":"252","author":"D Laurent","year":"1987","unstructured":"Laurent D: Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987, 252:C1-C9.","journal-title":"Am J Physiol"},{"key":"49_CR20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.hco.0000127134.66225.97","volume":"19","author":"J Moncrieff","year":"2004","unstructured":"Moncrieff J, Lindsay M, Dunn F: Hypertensive heart disease and fibrosis. Curr Opin Cardiol 2004, 19:326\u2013331.","journal-title":"Curr Opin Cardiol"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"MM Redfield","year":"2003","unstructured":"Redfield MM, Jacobsen SJ, Burnett JC, et al.: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003, 289:194\u2013202.","journal-title":"JAMA"},{"key":"49_CR22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/01.CIR.81.3.815","volume":"81","author":"D Levy","year":"1990","unstructured":"Levy D, Labib SB, Anderson KM, et al.: Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990, 81:815\u2013820.","journal-title":"Circulation"},{"key":"49_CR23","volume-title":"Textbook of Clinical Echocardiography","author":"C Otto","year":"2004","unstructured":"Otto C: Textbook of Clinical Echocardiography, edn 3. Philadelphia: Elsevier\/Saunders; 2004.","edition":"edn 3"},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9343(01)00841-5","volume":"111","author":"P Krishnaswamy","year":"2001","unstructured":"Krishnaswamy P, Lubien E, Clopton P, et al.: Utility of Bnatriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001, 111:274\u2013279.","journal-title":"Am J Med"},{"key":"49_CR25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/hc0502.103010","volume":"105","author":"E Lubien","year":"2002","unstructured":"Lubien E, DeMaria A, Krishnaswamy P, et al.: Utility of B-natriuretic peptide levels in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002, 105:595\u2013601.","journal-title":"Circulation"},{"key":"49_CR26","doi-asserted-by":"crossref","unstructured":"The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:303\u2013310.","DOI":"10.1056\/NEJM199108013250501"},{"key":"49_CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992, 327:669\u2013677.","journal-title":"N Engl J Med"},{"key":"49_CR28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, et al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. The US Carvedilol Heart Failure Study Group. N Engl J Med 1996, 334:1349\u20131355.","journal-title":"N Engl J Med"},{"key":"49_CR29","doi-asserted-by":"crossref","unstructured":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999, 353:9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"49_CR30","doi-asserted-by":"crossref","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353:2001\u20132007.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"49_CR31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","volume":"362","author":"JJ McMurray","year":"2003","unstructured":"McMurray JJ, Ostergren J, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARMAdded trial. Lancet 2003, 362:767\u2013771.","journal-title":"Lancet"},{"key":"49_CR32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"49_CR33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348:1309\u20131321.","journal-title":"N Engl J Med"},{"key":"49_CR34","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","volume":"351","author":"AL Taylor","year":"2004","unstructured":"Taylor AL, Ziesche S, Yancy C, et al.: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. The African-American Heart Failure trial Investigators. N Engl J Med 2004, 351:2049\u20132057.","journal-title":"N Engl J Med"},{"key":"49_CR35","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","volume":"275","author":"RE Schmieder","year":"1996","unstructured":"Schmieder RE, Martus P, Klingbeil A: Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996, 275:1507\u20131513.","journal-title":"JAMA"},{"key":"49_CR36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00001573-199909000-00003","volume":"14","author":"HO Ventura","year":"1999","unstructured":"Ventura HO, Loyalka P, Smart FW: Treatment of the hypertensive patient with microvascular angina. Curr Opin Cardiol 1999, 14:370\u2013374.","journal-title":"Curr Opin Cardiol"},{"key":"49_CR37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0002-8703(99)70187-0","volume":"138","author":"SH Poulsen","year":"1999","unstructured":"Poulsen SH, Jensen SE, Egstrup K: Effects of long-term adrenergic beta-blockade on left ventricular diastolic filling in patients with acute myocardial infarction. Am Heart J 1999, 138:710\u2013720.","journal-title":"Am Heart J"},{"key":"49_CR38","doi-asserted-by":"crossref","first-page":"H1534","DOI":"10.1152\/ajpheart.2000.279.4.H1534","volume":"279","author":"LS Matsubara","year":"2000","unstructured":"Matsubara LS, Matsubara BB, Okoshi MP, et al.: Alterations in myocardial collagen content affect rat papillary muscle function. Am J Physiol Heart Circ Physiol 2000, 279:H1534-H1539.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"49_CR39","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(99)00048-0","volume":"33","author":"JG Warner Jr","year":"1999","unstructured":"Warner JG Jr, Metzger DC, Kitzman DW, et al.: Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33:1567\u20131572.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR40","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","volume":"105","author":"J Diez","year":"2002","unstructured":"Diez J, Querejeta R, Lopez B, et al.: Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002, 105:2512\u20132517.","journal-title":"Circulation"},{"key":"49_CR41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahlof","year":"2002","unstructured":"Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995\u20131003.","journal-title":"Lancet"},{"key":"49_CR42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 2003, 362:777\u2013781. The most impressive data to date with regard to treatment of heart failure with preserved systolic function.","journal-title":"Lancet"},{"key":"49_CR43","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0002-9149(90)90937-V","volume":"66","author":"JF Setaro","year":"1990","unstructured":"Setaro JF, Zaret BL, Schulman DS, et al.: Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990, 66:981\u2013986.","journal-title":"Am J Cardiol"},{"key":"49_CR44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004872-200102000-00018","volume":"19","author":"WF Terpstra","year":"2001","unstructured":"Terpstra WF, May JF, Smit AJ, et al.: Long term effects of amlodipine and lisinopril on left ventricular mass and diastolic dysfunction in the elderly, in previously treated hypertensive patients: the ELVERA trial. J Hypertens 2001, 19:303\u2013309.","journal-title":"J Hypertens"},{"key":"49_CR45","first-page":"137","volume":"76","author":"R Hopf","year":"1987","unstructured":"Hopf R, Kaltenbach M: Ten-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists. Z Kardiol 1987, 76:137\u2013144.","journal-title":"Z Kardiol"},{"key":"49_CR46","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.CIR.72.4.853","volume":"72","author":"RO Bonow","year":"1985","unstructured":"Bonow RO, Dilsizian V, Rosing DR, et al.: Verapamilinduced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 1985, 72:853\u2013864.","journal-title":"Circulation"},{"key":"49_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"SA Hunt","year":"2005","unstructured":"Hunt SA, Abraham WT, Chin M, et al.: ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult. J Am Coll Cardiol 2005, 46:1\u201382.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-006-0049-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-006-0049-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-006-0049-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:16Z","timestamp":1559434456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-006-0049-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1007\/s11906-006-0049-0","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}